United Kingdom In Vitro Diagnostics Market to be Dominated by Infectious Disease Application through 2028

Increasing prevalence of chronic diseases and rising geriatric population are expected to drive the United Kingdom In Vitro Diagnostics Market in the forecast period 2024-2028.

According to TechSci Research report, “United Kingdom In Vitro Diagnostics Market – By Region, Competition Forecast and Opportunities, 2018-2028F,” the United Kingdom In Vitro Diagnostics Market is anticipated to grow at a significant rate in the forecast period, 2024-2028. The United Kingdom government has demonstrated its unwavering support for the life sciences sector, recognizing it as a vital component of the country's economy and public health infrastructure. Several initiatives have been launched to promote R&D and innovation in the field of IVDs. One such initiative is the Life Sciences Industrial Strategy, which aims to foster collaboration between academia, industry, and the National Health Service (NHS). Additionally, substantial funding has been allocated to support R&D activities, ensuring the availability of resources for developing cutting-edge diagnostic technologies.

With an aging population and an increasing prevalence of chronic diseases, there is a growing demand for non-invasive and point-of-care testing solutions in the United Kingdom. Non-invasive tests, such as liquid biopsies and breath analysis, offer patients a less invasive alternative to traditional diagnostic methods. Furthermore, point-of-care testing enables rapid and on-site diagnosis, reducing the turnaround time for test results and facilitating timely treatment decisions. The United Kingdom's R&D efforts are driving the development of these innovative diagnostic tools, addressing the evolving needs of healthcare providers and patients.

Despite the progress made in in vitro diagnostics, several challenges persist. Limited access and unavailability of healthcare professionals are some of the hurdles that need to be addressed to ensure equitable access to effective treatments for all patients, which may hamper the market's growth in the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “United Kingdom In Vitro Diagnostics Market“.

Based on product, the United Kingdom In Vitro Diagnostics Market is divided into Instruments, Reagents, and Other Products. The Reagents segment is expected to witness a rise over the forecast period. This can be attributed to the population's growing interest in healthy living and the frequency of routine medical exams to track general health. During the in vitro diagnostic processes, reagents, such as chemical, biological, or immunological components, solutions, and preparations, are actively used.

Based on test type, the United Kingdom In Vitro Diagnostics Market is divided into Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, and Other Types. The Immuno Diagnostics segment is anticipated to grow at a faster rate during the forecast period. This is attributed to the prevalence of regular health checkups and awareness about early diagnosis among the people of the country.

Based on usability, the United Kingdom In Vitro Diagnostics Market is divided into Disposable In Vitro Diagnostics Devices and Reusable In Vitro Diagnostics Devices. The Reusable In Vitro Diagnostics Devices segment is anticipated to grow at a faster rate during the forecast period.

Based on application, the United Kingdom In Vitro Diagnostics Market is divided into Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others. The Infectious Disease segment is expected to witness a rise over the forecast period. This is attributed to the prevalence of infectious diseases among the people of the United Kingdom and the fast and easy detection with in vitro diagnostics.

Based on end user, the United Kingdom In Vitro Diagnostics Market is divided into diagnostic laboratories, hospitals & clinics, and others. The Hospitals & Clinics segment is expected to witness a rise over the forecast period. This is attributed to the fact that they possess all of the In-vitro Diagnostics machinery and equipment. As a result, people prefer to receive In-vitro Diagnostics at hospitals and clinics.

Major companies operating in the United Kingdom In Vitro Diagnostics Market are:

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• BioMérieux UK
• Becton Dickinson and Company
• Danaher Corporation
• Agilent Technologies, Inc.
• Sysmex UK Ltd
• Siemens Healthineers
• Charles River Laboratories
• Bio-Rad Laboratories, Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The United Kingdom In Vitro Diagnostics Market is projected to experience substantial growth in the coming years. This can be attributed to the increasing incidence of chronic and infectious diseases, rising geriatric population and changing lifestyles. Furthermore, the healthcare sector's growing investments and government initiatives towards research and innovation are poised to drive the market, with expectations of sustained growth until 2028,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United Kingdom In Vitro Diagnostics Market By Product (Instrument, Reagent, Other Products), By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other Types), By Usability (Disposable In Vitro Diagnostics Devices, Reusable In vitro Diagnostics Devices), By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), By Region, Competition Forecast & Opportunities, 2018-2028F” has evaluated the future growth potential of United Kingdom In Vitro Diagnostics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United Kingdom In Vitro Diagnostics Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com